• By ICR Secretariat
  • Posted Thursday, April 15, 2021

Researchers lay out hypothesis for rare side effect linked to AstraZeneca vaccine


Researchers in Germany, Norway and Austria have put forward a hypothesis for why in some very rare cases the coronavirus vaccine developed by AstraZeneca and the University of Oxford seems to trigger an abnormal and potentially life-threatening combination of blood clotting and low platelet counts.